Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC12040L-KynurenineCAS: 2922-83-0纯度: >98.00%
L-Kynurenine是L-色氨酸的代谢物,也是一种芳香烃受体 (aryl hydrocarbon receptor; AhR) 激动剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC12040 | L-Kynurenine | 2922-83-0 | >98.00% | |
L-Kynurenine是L-色氨酸的代谢物,也是一种芳香烃受体 (aryl hydrocarbon receptor; AhR) 激动剂。 | ||||
| GC12041 | SNC 162 | 178803-51-5 | - | |
SNC 162 是一种 δ-阿片受体激动剂,IC50 为 0.94 nM。 | ||||
| GC12051 | Amiloride HCl dihydrate | 17440-83-4 | >98.00% | |
An Analytical Reference Standard | ||||
| GC12054 | KU-60019 | 925701-46-8 | >98.50% / >98.00% | |
A potent ATM kinase inhibitor | ||||
| GC12055 | Milnacipran HCl | 101152-94-7 | >99.50% | |
A serotonin and norepinephrine reuptake inhibitor | ||||
| GC12057 | Daclatasvir (BMS-790052) | 1214735-16-6 | - | |
An NS5A inhibitor | ||||
| GC12058 | TCS 359 | 301305-73-7 | >99.50% | |
A cell-permeable FLT3 inhibitor | ||||
| GC12059 | YM 976 | 191219-80-4 | - | |
A PDE4 inhibitor | ||||
| GC12061 | Tripelennamine HCl | 154-69-8 | >99.50% | |
Tripelennamine HCl 是一种乙二胺衍生物,是一种有效的组胺 H1 受体拮抗剂。 | ||||
| GC12064 | SB1317 | 937270-47-8 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC12065 | AVE 0991 | 304462-19-9 | >99.50% / >98.50% | |
A Mas receptor agonist | ||||
| GC12067 | P005091 | 882257-11-6 | >99.50% | |
P005091是一种有效的选择性泛素特异性蛋白酶7 (USP7) 抑制剂,EC50 值为4.2 μM。 | ||||
| GC12083 | CEP-33779 | 1257704-57-6 | >99.00% | |
A potent, orally available inhibitor of JAK2 | ||||
| GC12086 | PRIMA-1 | 5608-24-2 | >98.00% | |
A re-activator of the apoptotic function of mutant p53 proteins | ||||
| GC12087 | Canertinib dihydrochloride | 289499-45-2 | >99.00% | |
A pan-ErbB tyrosine kinase inhibitor | ||||
| GC12091 | SB742457 | 607742-69-8 | >98.00% | |
A 5-HT 6 receptor antagonist | ||||
| GC12096 | Semagacestat (LY450139) | 425386-60-3 | >99.50% | |
A pan γ-secretase inhibitor | ||||
| GC12112 | Lansoprazole sodium | 226904-00-3 | - | |
Proton pump inhibitor | ||||
| GC12115 | CUDC-907 | 1339928-25-4 | >99.50% | |
CUDC 是一种口服生物可利用的小分子 PI3K 和 HDAC 双重抑制剂,作用于 PI3K α 和 HDAC1 / 2 / 3 / 10,IC50 分别为 19 nm 和 1.7 nm / 5 nm / 1.8 nm / 2.8 nm .在 WSU DLCL2 细胞中评估了双功能 HDAC 和 PI3K 抑制剂 CUDC-907 的抗肿瘤活性。 | ||||
| GC12116 | Pitavastatin Calcium | 147526-32-7 | >99.00% | |
An HMG-CoA reductase inhibitor | ||||
| GC12117 | JNJ-26854165 (Serdemetan) | 881202-45-5 | >99.00% | |
An antagonist of MDM2 action | ||||
| GC12118 | SD 1008 | 960201-81-4 | - | |
SD 1008 是一种有效的 JAK 抑制剂。 SD 1008 抑制 STAT3、JAK2 和 Src 的酪氨酰磷酸化。 SD 1008 还降低 STAT3 依赖性荧光素酶活性。 SD 1008 通过直接阻断 JAK-STAT3 信号通路增强紫杉醇诱导的卵巢癌细胞凋亡。 | ||||
| GC12122 | Betamethasone Dipropionate | 5593-20-4 | >98.00% | |
倍他米松二丙酸酯是一种糖皮质激素类固醇,具有抗炎和免疫抑制能力。 | ||||
| GC12123 | sn-Glycero-3-phosphocholine | 28319-77-9 | >98.00% | |
A nootropic phospholipid | ||||
